Nawamin Pinpathomrat

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Venues

Vaccines

Journal of clinical medicine

NPJ vaccines

Viruses

This page only lists publications with an associated author ORCID identifier.

Publications

Ratchanon Sophonmanee, Perawas Preampruchcha, Jomkwan Ongarj, Bunya Seeyankem, Porntip Intapiboon, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
Intradermal Fractional ChAdOx1 nCoV-19 Booster Vaccine Induces Memory T Cells: A Follow-Up Study. Vaccines 12 (2) (2024)
Ratchanon Sophonmanee, Perawas Preampruchcha, Jomkwan Ongarj, Bunya Seeyankem, Porntip Intapiboon, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
Intradermal Fractional ChAdOx1 nCoV-19 Booster Vaccine Induces Memory T Cells: A Follow-Up Study. Vaccines 12 (2) (2024)
Porntip Intapiboon, Nawamin Pinpathomrat, Siriporn Juthong, Parichat Uea-Areewongsa, Jomkwan Ongarj, Boonjing Siripaitoon
Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report. Vaccines 11 (3) (2023)
Nonthanat Tongsengkee, Smonrapat Surasombatpattana, Wiwatana Tanomkiat, Pisud Siripaitoon, Narongdet Kositpantawong, Siripen Kanchanasuwan, Asma Navasakulpong, Nawamin Pinpathomrat, Arunee Dechaphunkul, Atthaphong Phongphithakchai, Thanaporn Hortiwakul, Boonsri Charoenmak, Sarunyou Chusri
Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP. Journal of clinical medicine 12 (4) (2023)
Nonthanat Tongsengkee, Smonrapat Surasombatpattana, Wiwatana Tanomkiat, Pisud Siripaitoon, Narongdet Kositpantawong, Siripen Kanchanasuwan, Asma Navasakulpong, Nawamin Pinpathomrat, Arunee Dechaphunkul, Atthaphong Phongphithakchai, Thanaporn Hortiwakul, Boonsri Charoenmak, Sarunyou Chusri
Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP. Journal of clinical medicine 12 (4) (2023)
Pimsiri Sripongpun, Nawamin Pinpathomrat, Ratchanon Sophonmanee, Jomkwan Ongarj, Purilap Seepathomnarong, Bunya Seeyankem, Naichaya Chamroonkul, Teerha Piratvisuth, Apichat Kaewdech, null null
Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study. Vaccines 11 (9) (2023)
Nonthanat Tongsengkee, Smonrapat Surasombatpattana, Wiwatana Tanomkiat, Pisud Siripaitoon, Narongdet Kositpantawong, Siripen Kanchanasuwan, Asma Navasakulpong, Nawamin Pinpathomrat, Arunee Dechaphunkul, Atthaphong Phongphithakchai, Thanaporn Hortiwakul, Boonsri Charoenmak, Sarunyou Chusri
Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP. Journal of clinical medicine 12 (4) (2023)
Porntip Intapiboon, Nawamin Pinpathomrat, Siriporn Juthong, Parichat Uea-Areewongsa, Jomkwan Ongarj, Boonjing Siripaitoon
Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report. Vaccines 11 (3) (2023)
Nonthanat Tongsengkee, Smonrapat Surasombatpattana, Wiwatana Tanomkiat, Pisud Siripaitoon, Narongdet Kositpantawong, Siripen Kanchanasuwan, Asma Navasakulpong, Nawamin Pinpathomrat, Arunee Dechaphunkul, Atthaphong Phongphithakchai, Thanaporn Hortiwakul, Boonsri Charoenmak, Sarunyou Chusri
Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP. Journal of clinical medicine 12 (4) (2023)
Porntip Intapiboon, Parichat Uae-Areewongsa, Jomkwan Ongarj, Ratchanon Sophonmanee, Purilap Seepathomnarong, Bunya Seeyankem, Smonrapat Surasombatpattana, Nawamin Pinpathomrat
Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases. NPJ vaccines 7 (1) (2022)
Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingviya, Pasuree Sangsupawanich, Sarunyou Chusri
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population. NPJ vaccines 7 (1) (2022)
Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingviya, Pasuree Sangsupawanich, Sarunyou Chusri
Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population. NPJ vaccines 7 (1) (2022)
Ratchanon Sophonmanee, Jomkwan Ongarj, Bunya Seeyankem, Purilap Seepathomnarong, Porntip Intapiboon, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine. Vaccines 10 (9) (2022)
Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Bunya Seeyankem, Sarunyou Chusri, Smonrapat Surasombatpattana, Nawamin Pinpathomrat
Regulatory T Cells Decreased during Recovery from Mild COVID-19. Viruses 14 (8) (2022)
Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population. Vaccines 9 (12) (2021)

Nawamin Pinpathomrat.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nawamin Pinpathomrat